Skip to content

Xin Wang

8 papers in the library · 91 citations · publishing 2021-2025

Papers

Sort Most recent Most cited

Intestinal γδ T17-IL-17A signaling disrupts hippocampal mitophagy in stress-induced depression and is restored by arketamine.

Journal of Neuroinflammation December 18, 2025 Mengqi Han, Bing Xie, Yuan Yu et al.

Chronic stress precipitates depression, yet how gut-immune-brain interactions translate stress into mood pathology remains unclear. We tested the hypothesis that stress-primed small intestinal γδ T cells drive hippocampal mitochondrial dysfunction and depression-like behavior via interleukin-17A (IL-1A). In mice exposed to chronic restraint stress (CRS), we combined behavioral assays...

Acupuncture effect on brain default mode network connectivity in breast cancer patients with hot flashes: A randomized controlled trial.

European Journal of Cancer September 12, 2025 Zhuo-Nan Wang, Gui-Hua Tian, Jie-Rui Ding et al.

OBJECTIVE To use functional MRI to assess the effect of acupuncture on brain resting-state functional connectivity in breast cancer patients with hot flashes. METHODS A total of 24 breast cancer patients experiencing hot flashes (BC-HF) underwent 5 weeks of acupuncture treatment and follow-up at 4-6 months after therapy. The control groups included 35 patients with breast cancer without hot...

Effects of mindfulness-based interventions on mental health among women with fetal loss: A systematic review and meta-analysis.

Midwifery July 15, 2025 Xin Wang, Ying Luo, Ying Gao et al.

Mindfulness-based interventions (MBIs) have shown potential in reducing maternal negative emotions, but their effectiveness for women with fetal loss requires further investigation. This study aimed to evaluate the effects of MBIs on mental health outcomes among these women. Randomized controlled trials (RCTs) on MBIs for women with fetal loss were retrieved from eight databases, covering...

DOI: 10.1016/j.midw.2025.104520 (opens in new tab) Full text (opens in new tab) Depression Fetal loss Mental health Mindfulness-based interventions

Psilocybin biosynthesis enhancement through gene source optimization.

Metabolic Engineering April 16, 2025 Madeleine R Keller, Madeline G. Mckinney, Abhishek K. Sen et al. 8 citations

Psilocybin, the prodrug to the psychoactive compound in 'magic' mushrooms, is currently being studied in clinical trials as a treatment for severe mental health conditions, such as depression and anxiety. Previous reports of psilocybin biosynthesis as reconstituted in E. coli reported maximum titers of 1.16 g/L, exclusively using genes from the most common recreationally used mushroom,...

DOI: 10.1016/j.ymben.2025.04.003 (opens in new tab) Full text (opens in new tab) Gene source optimization Gymnopilus dilepis Norbaeocystin methyltransferase Promoter library +7

Evaluation of TrpM and PsiD substrate promiscuity reveals new biocatalytic capabilities

Biotechnology Progress June 18, 2024 Xin Wang, Fiona C. Kanis, Caroline N. Broude et al. 2 citations

Abstract N ‐methylated tryptamines, such as the hallucinogenic natural products, psilocybin and N,N ‐dimethyltryptamine (DMT), are gaining interest from the medical community due to their potential as next generation treatments for mental health disorders. The clinical relevance of these compounds has driven scientists to develop biosynthetic production routes to a number of tryptamine drug...

DOI: 10.1002/btpr.3492 (opens in new tab) Psilocybin Biosynthesis Tryptamines Biochemistry +2

A randomized controlled trial of mindfulness-based cognitive therapy for major depressive disorder in undergraduate students: Dose- response effect, inflammatory markers and BDNF.

Psychiatry Research 2024 Wei Liu, Jing Yuan, Yun Wu et al. 19 citations

To examine the dose-response effect of mindfulness-based cognitive therapy (MBCT) for college students with major depressive disorder (MDD), a randomized control trial with MBCT and a wait-list (WL) group was performed. All participants were invited to self-administer a set of questionnaires at baseline, mid-intervention (4th week), and post-intervention (8th week) by the 9-item Patient Health...

DOI: 10.1016/j.psychres.2023.115671 (opens in new tab) Full text (opens in new tab) Major depressive disorder Mindfulness-based cognitive therapy Randomized control trial The dose-response effect

“Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli”

Biotechnology and Bioengineering June 20, 2023 Jessica E. Flower, William J Gibbons, Alexandra M. Adams et al. 26 citations

Abstract Traditional psychedelics are undergoing a transformation from recreational drugs, to promising pharmaceutical drug candidates with the potential to provide an alternative treatment option for individuals struggling with mental illness. Sustainable and economic production methods are thus needed to facilitate enhanced study of these drug candidates to support future clinical efforts....

DOI: 10.1002/bit.28480 (opens in new tab) Psilocybin Co-cultures Enzyme promiscuity Tryptamine +6

Efficacy Evaluation of Neurofeedback-Based Anxiety Relief

Frontiers in Neuroscience October 28, 2021 Chao Chen, Xiaolin Xiao, Abdelkader Nasreddine Belkacem et al. 36 citations

Anxiety disorder is a mental illness that involves extreme fear or worry, which can alter the balance of chemicals in the brain. This change and evaluation of anxiety state are accompanied by a comprehensive treatment procedure. It is well-known that the treatment of anxiety is chiefly based on psychotherapy and drug therapy, and there is no objective standard evaluation. In this paper, the...